Who invested in Nuvig Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$161Mraised across 1 round since 2024, from 1 source

Latest round: Series B, $161MDec 2024
Investors: 5

See who backed them

The rounds

Dec 2024
Series B$161M
Source recorded

Founders and team

From Nuvig Therapeutics's own website: 7 on the team.

Bella OgunoVice President, Development Operations
Yvonne CoffeyVice President, Regulatory Affairs
Nuvig TherapeuticsCofounder & Chief Scientific Officer
Heidi RemsbergDirector of Operations/HR Business Partner
Jessica BrightSenior Director, Research Immunology
Karen GrimmSenior Director of Analytical Development
Timothy AndersonDirector

Everyone who backed them

Norwest Venture PartnersVC firm1round

B CapitalVC firm1round

Novo HoldingsVC firm1round

Digitalis VenturesVC firm1round

Mission BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Nuvig Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.